FI943872A0 - 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina - Google Patents

2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina

Info

Publication number
FI943872A0
FI943872A0 FI943872A FI943872A FI943872A0 FI 943872 A0 FI943872 A0 FI 943872A0 FI 943872 A FI943872 A FI 943872A FI 943872 A FI943872 A FI 943872A FI 943872 A0 FI943872 A0 FI 943872A0
Authority
FI
Finland
Prior art keywords
quinolithine
methono
derivative
receptor antagonist
antagonist
Prior art date
Application number
FI943872A
Other languages
English (en)
Swedish (sv)
Other versions
FI105917B (fi
FI943872A (fi
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI943872A0 publication Critical patent/FI943872A0/fi
Publication of FI943872A publication Critical patent/FI943872A/fi
Application granted granted Critical
Publication of FI105917B publication Critical patent/FI105917B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943872A 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi FI105917B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92400474 1992-02-24
EP92400474 1992-02-24
PCT/US1993/000880 WO1993017019A1 (en) 1992-02-24 1993-02-03 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
US9300880 1993-02-03

Publications (3)

Publication Number Publication Date
FI943872A0 true FI943872A0 (fi) 1994-08-23
FI943872A FI943872A (fi) 1994-08-23
FI105917B FI105917B (fi) 2000-10-31

Family

ID=8211614

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943872A FI105917B (fi) 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0628043A1 (fi)
JP (1) JPH07504192A (fi)
KR (1) KR100287933B1 (fi)
AU (1) AU675060B2 (fi)
CA (1) CA2130563C (fi)
FI (1) FI105917B (fi)
HU (1) HU216831B (fi)
IL (1) IL104821A (fi)
MX (1) MX9300948A (fi)
NO (1) NO943101D0 (fi)
NZ (1) NZ249346A (fi)
TW (1) TW226374B (fi)
WO (1) WO1993017019A1 (fi)
ZA (1) ZA931146B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002537255A (ja) 1999-02-18 2002-11-05 ノバルティス アクチエンゲゼルシャフト リウマチ性炎症性プロセスに対する５−ｈｔ３レセプターアンタゴニストの全身的使用
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
CN104248763A (zh) 2005-03-07 2014-12-31 芝加哥大学 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129153T1 (de) * 1988-02-23 1995-11-15 Merrell Dow Pharma Verwendung von chinolizin- und chinolizinon- derivaten zur herstellung von arzneimitteln.
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
FI105917B (fi) 2000-10-31
KR950700297A (ko) 1995-01-16
NO943101L (no) 1994-08-23
JPH07504192A (ja) 1995-05-11
NO943101D0 (no) 1994-08-23
CA2130563C (en) 1997-11-11
WO1993017019A1 (en) 1993-09-02
ZA931146B (en) 1993-09-14
AU3603493A (en) 1993-09-13
KR100287933B1 (ko) 2001-05-02
IL104821A (en) 1997-01-10
MX9300948A (es) 1993-08-01
NZ249346A (en) 1995-10-26
HU9402436D0 (en) 1994-10-28
FI943872A (fi) 1994-08-23
IL104821A0 (en) 1993-06-10
TW226374B (fi) 1994-07-11
HUT68249A (en) 1995-06-28
AU675060B2 (en) 1997-01-23
CA2130563A1 (en) 1993-09-02
HU216831B (hu) 1999-09-28
EP0628043A1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
DK0808312T3 (da) Indolderivater som 5-HT-receptorantagonist
DK0804419T3 (da) Quinolinderivater som tachykinin NK 3-receptor-antagonister
ATE201016T1 (de) Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
NO943348L (no) Kondenserte indolderivater som 5HT4-reseptorantagonister
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
FI963786A0 (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
AU2314195A (en) Benzofuran derivatives as d4 receptor antagonists
DK0854867T3 (da) Tetrahydroquinoliner som NMDA-antagonister
DK0710230T3 (da) Som CCK- eller gastrinantagonister anvendelige 1,5-benzodiazepinderivater
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO943101D0 (no) 2,6-metano-2H-kinolizinderivat som 5-HT3-reseptorantagonist
NO985972L (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
FI922903A (fi) 4-acetoxipiperidin derivat, deras framstaellningsfoerfarande och anvaendning som antagonist foer muskarina m-3 receptorer.
NO974205L (no) Heterocyklisk-substituerte piperazinonderivater som tachykininreceptor-antagonister
FI943359A (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
NO983656D0 (no) Heterocyklyl-ergolinderivater som 5-HT1A reseptorligander
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
FI941117A (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina
ZA9600758D (en) Idole derivatives as 5-ht receptor antagonist.
NO963775D0 (no) Indol-derivater som CCK-reseptorantagonister
FI924789A (fi) Gamma-interferoners loesliga, stympade receptor
ITBO910231V0 (it) macchina spaccafondelli per edilizia.
FI924721A (fi) 2,3-dideoxy-4-tioribonukleosider som antivirala aemnen

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired